Henry Schein (WBO:HSIC) EBIT: €595 Mil (TTM As of Mar. 2026)


WBO:HSIC Henry Schein Inc WBO:HSIC
80 GF Score
Price €73.00
GF Value €73.69
! 8 Warning Signs
View Full Analysis

What is Henry Schein EBIT?

Henry Schein WBO:HSIC +3.55% 80 EBIT is €595 Mil as of Mar. 2026. GuruFocus rates WBO:HSIC with a GF Score™ of 80/100 and a GF Value™ of €73.69. The stock has 8 warning signs investors should review.

Henry Schein's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was €163 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was €595 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Henry Schein's annualized ROC % for the quarter that ended in Mar. 2026 was 6.58%. Henry Schein's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 25.24%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Henry Schein's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 4.64%.


Henry Schein  (WBO:HSIC) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Henry Schein's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=671.24 * ( 1 - 25.33% )/( (7434.924 + 7809.22)/ 2 )
=501.214908/7622.072
=6.58 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=9577.61 - 2009.462 - ( 133.224 - max(0, 2756.712 - 3812.256+133.224))
=7434.924

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=9777.96 - 1849.37 - ( 119.37 - max(0, 2851.905 - 3889.04+119.37))
=7809.22

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Henry Schein's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=653.94/( ( (787.388 + max(1669.57, 0)) + (804.45 + max(1920.3, 0)) )/ 2 )
=653.94/( ( 2456.958 + 2724.75 )/ 2 )
=653.94/2590.854
=25.24 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1409.954 + 1709.708 + 559.37) - (2009.462 + 0 + 0)
=1669.57

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1486.935 + 1742.11 + 540.625) - (1849.37 + 0 + 4.5474735088646E-13)
=1920.3

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Henry Schein's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=594.77/12808.963
=4.64 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Henry Schein EBIT Related Terms


Henry Schein EBIT Historical Data

* Premium members only.

The historical data trend for Henry Schein's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Henry Schein EBIT Chart

Henry Schein Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 759.33 713.66 576.79 615.02 583.28

Henry Schein Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 166.50 137.85 146.54 146.89 163.49

WBO:HSIC vs AHG, ACH, EDAP: EBIT Comparison

For the Medical Distribution subindustry, Henry Schein's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Henry Schein EV-to-EBIT vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Henry Schein's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Henry Schein's EV-to-EBIT falls into.


WBO:HSIC
80GF Score
Henry Schein Inc WBO:HSIC
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Henry Schein EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €595 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of €595 Mil mean?
Henry Schein (WBO:HSIC) has a EBIT of €595 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Henry Schein.
Is Henry Schein's EBIT too high?
Henry Schein's current EBIT is €595 Mil. Overall, Henry Schein has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Henry Schein's EBIT compare to AHG and ACH?
Henry Schein's EBIT of €595 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Distribution company?
A good EBIT depends on the Medical Distribution industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Henry Schein. Henry Schein's current EBIT is €595 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Henry Schein stock overvalued right now?
Henry Schein (WBO:HSIC) has a current EBIT of €595 Mil. The stock's GF Value™ is €73.69, compared to a current price of €73.00 — trading 0.9% below its estimated fair value. The current EBIT is €595 Mil. Henry Schein's overall GF Score™ is 80/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Henry Schein (WBO:HSIC), the current EBIT is €595 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Henry Schein (WBO:HSIC) Overvalued in 2026?

Based on GuruFocus' analysis, Henry Schein stock appears to be undervalued. The current stock price of €73.00 is trading 0.9% below its estimated GF Value™ of €73.69.

Key valuation signals for WBO:HSIC:

  • EBIT: €595 Mil
  • GF Value™: €73.69 vs. price of €73.00 (0.9% below fair value)
  • GF Score™: 80/100 with 8 warning signs

No single metric tells the full story. See the WBO:HSIC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Henry Schein Business Description

Address 135 Duryea Road, Melville, NY, USA, 11747
Henry Schein Inc is a solutions company for healthcare professionals. It offers healthcare equipment, products, and services to office-based dental and medical practitioners, as well as alternative sites of care. The company's reportable segments are: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. It generates maximum revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting, and other practice services.
80GF Score

Get the complete analysis for WBO:HSIC

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€73.00
Price
€73.69
GF Value